Despite his denials, he does get paid. (Can you imagine a rational person posting every few minutes, day after day, basically the same message for no gain--as Mckiddn has stated on numerous occasions that he is notshort). He is being paid for his every post and for each response to Topics that he starts).
He gets paid for each of his bashing posts AND for each response to the Topics he introduces. Hence, when you wish to take issue with the lies and disingenuous comments he posts, be sure to use your own Topic.
Mckiddn, "A parent company is a company that owns enough voting stock in another firm to control management and operation by doing and influencing or electing."
Hence, Galena is NOT RXII's parent company.
You are either uninformed or purposely post lies. Actually, as is evident from your posting history, you are both: woefully uniformed and a calculating liar.
Mckiddn, your use of the term "parent company" is misleading. There is no current relationship--stock, ownership, research area, etc,-- between the two companies. Yes, years ago Rxi split off from gale, but no present relationship or association.
Just takes a couple hundred shares to knock off $.20. Took so many hundreds of thousands shares to increase .20. As posted several days ago, so much mere share swapping on the up leg. Nevertheless, looked good for a few days, including a day holding up on lower volume. But news never emerged, no filing revealing a new buyer. Looks like permanent gains just won't be allowed--unless an indisputably significant transactional event occurs: a merger or buyout. I even doubt that good clinical results would pry this stock from the manipulative hands that keep swapping us into the cellar imprisoning it: from some of the same hands that keep paying Mckiddn for his incessant negative commentary. No, what's required is a major transactional event: one that will speak for itself in terms of value.
Stockasaur, as you have no doubt noted, this is the sickest board you'll ever encounter. It's dominated by psychopath Mckiddn, who posts the same messages over and over throughout the day, the week, the year. Not only that, he will will copy verbatim those posts that are written by others about him, and then substitute the writers's name for his own, as subject for his plagiarized posts.
In answer to your question, while there is no debt and enough cash to get the company through much of 2017, more will be needed that would not be supplied soon enough by revenues from products still to be developed; and, yes, this could come through dilution. But, the company is actively seeking partnerships, or even perhaps a buyer or merger that could supply cash needs as well as deepen pipeline-- and has announced the hiring of a company to assist in this search. This could happen and be announced in a day from now, a week, a month-- or not at all. The present market cap is minuscule, and should their intellectual property prove productive and efficacious either in the area of skin or ocular scarring, in cosmeceuticals, or other variety of applied areas where their patented means of self delivered rnai might revolutionize, its pps could rapidly multiply.
(Psychopath McKiddn diarrhetically bashes, but he has no way of knowing whether present trials will prove successful,etc, and has no technical expertise, nor any tutored insights into the science on which the company is largely based.)
And, sharply reduced volume during the down phase today. Both interesting signs. (Also the jump at the buy-on-close.) All very curious, and, for now at least, positive.
Given extraordinary buying volume as well as low cap and precipitous post-split decline,you'd think stock would be up more than 35%. If this were a " normal" stock, without share swapping, algorithmic game playing, etc., that we've noted in the last year, I think such evident buying would have propelled pps to near $4 , given huge float % trading we've seen. Without immediate news, I am not confident present price can be sustained near term. Sure, it Should be, but there's a short factory out there for RXI.
Hanna, float is 5.14 million, not 4m. Surprised, given your large stock holding and daily posting and interest in the company that you would not even know this.
Given no sec filing yesterday regarding new or expanded purchases of RXI stock, if no news this morning by 9am, I will be very wary of present sustainability of this rally. Perhaps part of this volume was more share swapping that we've witnessed over the last year, perhaps part of the volume was due to some newsletter, but without a filing or news this morning, despite this most extraordinary 2-day volume, I can't see rally continuing beyond this morning based only on either rumor or leak.
Again, would wager a single buyer-- if true, should be filing any minute.
This morning's spike may well be largely panicky short covering. My best guess for yesterday's and part of today's volume is either a new company taking a position in Rxii or present holder expanding its position. Given the number of shares involved, I'd say likely we'll see SEC filing by 5pm today. No way to know, right now, whether the relevant party will be accreteing more shares the rest of the day.
Extraordinary volume. Meaning?
He knows, before anyone else, the results of all the trials. Or, he just gets paid for each negative post--for each inane, repetitive, diarrhetic post. Or, he's just sicker than even we can imagine.
With esp. high volume today, what would prompt Mckiddn's hapless " less volume" post just now?
Is he really being paid for each post and must stretch to find some new topic today? Or is it just a paniced narcism with such desperate need for attention that he feels a plummet into the abyss of nothingness unless he affirms his pathetic existence with myriad posts every day?